Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Journal of the American Society of Nephrology : JASN
|
May 3, 2023
Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Edouard L Fu
Kidney International
|
January 5, 2023
Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
Edouard L Fu, Alexander Kutz, Rishi J Desai
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 14, 2025
Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor versus clopidogrel in older adults with acute coronary syndrome: a target trial emulation study
Carole A Marxer, Paul Hjemdahl, Juan J Carrero, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 24, 2023
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
Edouard L Fu, Elvira D'Andrea, Deborah J Wexler, et al.
Diabetes Research and Clinical Practice
|
June 14, 2024
Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
Daniel V O'Hara, Roemer J Janse, Edouard L Fu, et al.
Kidney International
|
June 17, 2023
A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality
Anne-Laure Faucon, Edouard L Fu, Bénédicte Stengel, et al.
Kidney International
|
November 26, 2021
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
Yang Xu, Edouard L Fu, Catherine M Clase, et al.
Journal of Cardiac Failure
|
October 3, 2022
Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care
Ankeet S Bhatt, Muthiah Vaduganathan, Min Zhuo, et al.
Clinical Kidney Journal
|
August 26, 2024
Decoy receptors as biomarkers for exploring aetiology and designing new therapies
Carmine Zoccali, Giovanni Tripepi, Vianda Stel, et al.
Circulation. Heart Failure
|
October 19, 2020
Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease
Edouard L Fu, Alicia Uijl, Friedo W Dekker, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Journal of the American Society of Nephrology : JASN
|
May 3, 2023
Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Edouard L Fu
Kidney International
|
January 5, 2023
Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
Edouard L Fu, Alexander Kutz, Rishi J Desai
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 14, 2025
Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor versus clopidogrel in older adults with acute coronary syndrome: a target trial emulation study
Carole A Marxer, Paul Hjemdahl, Juan J Carrero, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 24, 2023
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
Edouard L Fu, Elvira D'Andrea, Deborah J Wexler, et al.
Diabetes Research and Clinical Practice
|
June 14, 2024
Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
Daniel V O'Hara, Roemer J Janse, Edouard L Fu, et al.
Kidney International
|
June 17, 2023
A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality
Anne-Laure Faucon, Edouard L Fu, Bénédicte Stengel, et al.
Kidney International
|
November 26, 2021
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
Yang Xu, Edouard L Fu, Catherine M Clase, et al.
Journal of Cardiac Failure
|
October 3, 2022
Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care
Ankeet S Bhatt, Muthiah Vaduganathan, Min Zhuo, et al.
Clinical Kidney Journal
|
August 26, 2024
Decoy receptors as biomarkers for exploring aetiology and designing new therapies
Carmine Zoccali, Giovanni Tripepi, Vianda Stel, et al.
Circulation. Heart Failure
|
October 19, 2020
Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease
Edouard L Fu, Alicia Uijl, Friedo W Dekker, et al.
Page
of 8